Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Gurdane Bhutani - aVenture Research

Gurdane Bhutani

AddedMar 31, 2024

UpdatedOct 14, 2026

Gurdane Bhutani

Gurdane Bhutani

Co-Founder, FundRx

Gurdane Bhutani's Career

FundRx

Investment Firm

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

New York City, NY, US

Co-Founder

MBX Capital

Investment FirmNew York City, NY, US

Co-Founder

Freedom Biosciences

Seed$10.5MSan Francisco, CA, US

Board Member· Board

Contraline

Series A$24.6MCharlottesville, VA, US

Board Member· Board

CareRev

$51.3MLos Angeles, CA, US

Board Member· Board

People Similar to Gurdane Bhutani

Brian CheeBoard Member · August Bioservices

Will CowenCo-Founder · Lrvhealth

Robert MittendorffBoard Member · Impel Pharmaceuticals

Karl KipkeCo-Founder · Revx Technologies

Leadership at FundRx

Jainal BhuiyanBoard Member

Zeshan MuhammediCo-Founder & CEO

Similar to FundRx

The FundNew York City, NY, USest. 2017The FundNew York City, NY, US · est. 2017

NYC-based financial services firm, THE FUND, actively supports emerging entrepreneurs across 150 companies.

Investment Firm30

dRx CapitalBasel, Basel-Stadt, CHest. 2015dRx CapitalBasel, Basel-Stadt, CH · est. 2015

dRx Capital: Novartis' digital health venture fund, investing in tech transforming healthcare & optimizing pharma practices.

Investment Firm6

Foundation Venture Capital GroupNew Brunswick, NJ, USest. 2005Foundation Venture Capital GroupNew Brunswick, NJ, US · est. 2005

Foundation Venture Capital Group: U.S.-based firm providing pre-seed funding to new life science companies.

Investment Firm7

Rhythm VCNew York City, NY, USVenture Capital Fundest. 2018Rhythm VCNew York City, NY, US · est. 2018

Rhythm VC is a New York-based venture capital firm focused on early-stage healthcare investments.

Investment Firm2

Leadership at CareRev

William PattersonCo-Founder

Derrek LongCo-Founder

Sofia PessanhaCOO

Similar to CareRev

ClipboardSan Francisco, CA, USHealthcare Staffingest. 2016ClipboardSan Francisco, CA, US · est. 2016

App-based marketplace connecting healthcare pros with on-demand shifts.

Series C · $94.2M600

NurseDashHouston, TX, USHealthcare, Staffingest. 2017NurseDashHouston, TX, US · est. 2017

NurseDash: On-demand staffing marketplace connecting healthcare providers with qualified candidates.

Seed · $625k235

BemloStockholm, Stockholm County, SEHealthcare, Healthcare Staffing, Staffingest. 2021BemloStockholm, Stockholm County, SE · est. 2021

Bemlo: Streamlining healthcare staffing with a flexible, direct-hire platform.

DirectShiftsNew York City, NY, USHealthcare Staffingest. 2017DirectShiftsNew York City, NY, US · est. 2017

Connecting healthcare pros with hospitals for jobs & locum tenens.

Similar to MBX Capital

Milkbox PartnersNew York City, NY, USest. 2013Milkbox PartnersNew York City, NY, US · est. 2013

Milkbox Partners: A New York-based venture capital firm specializing in early-stage investments.

Investment Firm4

MB Venture PartnersMemphis, TN, USest. 2001MB Venture PartnersMemphis, TN, US · est. 2001

MB Venture Partners: A Tennessee-based venture capital firm focused on life sciences investments.

Investment Firm8

m]x[v CapitalNew York City, NY, USest. 2021m]x[v CapitalNew York City, NY, US · est. 2021

m]x[v Capital: A New York-based venture capital firm specializing in early-stage B2B and SaaS investments.

Investment Firm5

MBM CapitalNew York City, NY, USest. 2021MBM CapitalNew York City, NY, US · est. 2021

NYC-based financial firm investing in tech-enabled businesses across finance, HR, data, and e-commerce.

Investment Firm13

Leadership at Freedom Biosciences

Dina BurkitbayevaCo-Founder & CEO

Hunter R. BouchardCo-Founder

Similar to Freedom Biosciences

Reset PharmaceuticalsNew York City, NY, USPharmaceuticalsest. 2020Reset PharmaceuticalsNew York City, NY, US · est. 2020

Reset Pharma: A biotech firm specializing in the development of novel psychedelic treatments.

Series A · $11.1M37

Lykos TherapeuticsSan Jose, CA, USPharmaceuticalsest. 2014Lykos TherapeuticsSan Jose, CA, US · est. 2014

Lykos Therapeutics: Revolutionizing mental health with innovative, science-backed psychedelic therapies.

Series A · $100M175

Mindstate Design LabsPittsburgh, PA, USTherapeuticsest. 2021Mindstate Design LabsPittsburgh, PA, US · est. 2021

Biotech firm creating advanced psychedelic treatments for mental health.

Seed · $11.6M13

Gilgamesh PharmaceuticalsNew York City, NY, USBiotechest. 2019Gilgamesh PharmaceuticalsNew York City, NY, US · est. 2019

Gilgamesh Pharmaceuticals: Innovating in mental health with safer, effective biotech solutions.

Series B · $68.4M22

Leadership at Contraline

John HerrCo-Founder

Kevin EisenfratsCo-Founder

Michael KingBoard Member

Similar to Contraline

YourChoice TherapeuticsBerkeley, CA, USPharmaceuticalsest. 2018YourChoice TherapeuticsBerkeley, CA, US · est. 2018

YourChoice Therapeutics develops innovative non-hormonal contraceptives for both genders.

Series A · $16.7M8

YourChoice TherapeuticsContraceptivesYourChoice Therapeutics

Revolutionizing global contraceptive market with non-hormonal options for women and men.

Powell Development GroupTorrance, CA, USCondoms, Contraceptivesest. 2013Powell Development GroupTorrance, CA, US · est. 2013

Provider of the Galactic Cap, a revolutionary male contraceptive enhancing pleasure and preventing pregnancy.

Angel · $163.7k30

Next Life SciencesSan Luis Obispo, CA, USMedical ProceduresNext Life SciencesSan Luis Obispo, CA, US

NEXT Life Sciences pioneers the Plan A™ procedure, marketing the unique, proven Vasalgel® technology.

Seed · $1.6M30